Browsing by Author "Gresh, Lionel"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemOpen AccessThe development of aptamer-based probes for the detection of TB antigens ESAT-6.CFP-10 potential TB diagnostic tools(2013) Maserumule, Matsopiane Charlotte; Dheda, Keertan; Khati, Makobetsa; Gresh, LionelLack of point-of-care (PoC) diagnostic tools for TB hinders control of the disease, particularly in resource-limited, high HIV and TB prevalence countries. Therefore, there is a need for simple, rapid, accurate, and affordable PoC diagnostics to detect active TB early enough for opportune intervention. To develop TB detection probes that will constitute such diagnostics, our research group recently isolated DNA aptamers that bind to a putative marker for active TB; the ESAT-6.CFP-10 heterodimer. Aptamers are highly specific artificial mimics of antibodies that have shown great prospects in diagnostic applications. The aim of this study was to characterise the anti-ESAT-6.CFP-10 aptamers, and to optimise them into more specific and affordable detection probes for the development of potential PoC TB diagnostic tools.
- ItemOpen AccessHigh-throughput sequencing enhanced phage display identifies peptides that bind mycobacteria(Public Library of Science, 2013) Ngubane, Nqobile A C; Gresh, Lionel; Ioerger, Thomas R; Sacchettini, James C; Zhang, Yanjia J; Rubin, Eric J; Pym, Alexander; Khati, MakobetsaBacterial cell wall components have been previously used as infection biomarkers detectable by antibodies. However, it is possible that the surface of the Mycobacterium tuberculosis ( M. tb ), the causative agent of tuberculosis (TB), also possesses molecules which might be non-antigenic. This makes the probing of biomarkers on the surface of M. tb cell wall difficult using antibodies. Here we demonstrate the use of phage display technology to identify peptides that bind to mycobacteria. We identified these clones using both random clone picking and high throughput sequencing. We demonstrate that random clone picking does not necessarily identify highly enriched clones. We further showed that the clone displaying the CPLHARLPC peptide which was identified by Illumina sequencing as the most enriched, binds better to mycobacteria than three clones selected by random picking. Using surface plasmon resonance, we showed that chemically synthesised CPLHARLPC peptide binds to a 15 KDa peptide from M.tb H37Rv whole cell lysates. These observations demonstrate that phage display technology combined with high-throughput sequencing is a powerful tool to identify peptides that can be used for investigating potential non-antigenic biomarkers for TB and other bacterial infections.